Archive for: pricing




  • POST

Prescription Drug: Legislation

House Judiciary Committee Marks Up Cost Reduction Bills

On Tuesday, April 30th, the House Judiciary Committee will mark-up several bills aimed at reducing the cost of prescription drugs. These bills are: H.R. 965, the “CREATES Act”; H.R. 2375, the “Preserve Access to Affordable Generics and Biosimilars Act”; H.R. 2374, the “Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act”; and…


Prescription Drug: Regulation

CMS Issues Pair of Rules on Line Item Extension Drugs

CMS issues pair of final rules addressing line item extension drugs.


Prescription Drug: Legislation

Bipartisan Legislation Introduced by Senators Grassley and Klobuchar

The bill would temporarily allow drugs to be imported from certain other countries if facing a shortage or lack of competition.


Payment Innovation: Other

CMS Proposes Changes for MA and Part D Plans: Coverage Changes for Protected Class Drugs, Step Therapy Requirements and Greater Price Transparency for Medicare Beneficiaries

On November 26, 2018, CMS released a proposed rule that would allow for changes in 2020 to coverage of protected class drugs, establish new requirements for when MA plans may apply step therapy as a utilization management tool for Part B drugs and implement electronic tools to increase drug price transparency for Medicare beneficiaries.


Load more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope